TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 165 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,127,000 | -63.1% | 18,877 | -63.3% | 0.01% | -66.7% |
| Q2 2017 | $5,762,000 | -11.4% | 51,420 | -7.8% | 0.04% | -23.4% |
| Q1 2017 | $6,507,000 | +13.5% | 55,799 | +2.4% | 0.05% | +4.4% |
| Q4 2016 | $5,735,000 | +2.2% | 54,478 | +7.2% | 0.04% | -4.3% |
| Q3 2016 | $5,614,000 | -24.1% | 50,800 | 0.0% | 0.05% | -25.4% |
| Q2 2016 | $7,396,000 | +1816.1% | 50,800 | +1932.0% | 0.06% | +1475.0% |
| Q4 2015 | $386,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |